- Home
- KOD vs NKSH Comparison
KOD vs NKSH Comparison
Compare KOD & NKSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KOD
- NKSH
- Stock Information
- Founded
- KOD 2009
- NKSH 1891
- Country
- KOD United States
- NKSH United States
- Employees
- KOD N/A
- NKSH N/A
- Industry
- KOD Biotechnology: Biological Products (No Diagnostic Substances)
- NKSH Major Banks
- Sector
- KOD Health Care
- NKSH Finance
- Exchange
- KOD Nasdaq
- NKSH Nasdaq
- Market Cap
- KOD 186.3M
- NKSH 182.9M
- IPO Year
- KOD 2018
- NKSH N/A
- Fundamental
- Price
- KOD $8.72
- NKSH $29.25
- Analyst Decision
- KOD Hold
- NKSH Strong Buy
- Analyst Count
- KOD 5
- NKSH 1
- Target Price
- KOD $6.80
- NKSH $38.00
- AVG Volume (30 Days)
- KOD 484.9K
- NKSH 15.9K
- Earning Date
- KOD 11-14-2024
- NKSH 10-24-2024
- Dividend Yield
- KOD N/A
- NKSH 5.02%
- EPS Growth
- KOD N/A
- NKSH N/A
- EPS
- KOD N/A
- NKSH 1.44
- Revenue
- KOD N/A
- NKSH $43,450,000.00
- Revenue This Year
- KOD N/A
- NKSH N/A
- Revenue Next Year
- KOD N/A
- NKSH $14.93
- P/E Ratio
- KOD N/A
- NKSH $20.81
- Revenue Growth
- KOD N/A
- NKSH N/A
- 52 Week Low
- KOD $2.19
- NKSH $26.50
- 52 Week High
- KOD $11.60
- NKSH $35.00
- Technical
- Relative Strength Index (RSI)
- KOD 64.72
- NKSH 34.12
- Support Level
- KOD $8.03
- NKSH $30.80
- Resistance Level
- KOD $9.55
- NKSH $31.00
- Average True Range (ATR)
- KOD 0.89
- NKSH 1.05
- MACD
- KOD -0.08
- NKSH -0.38
- Stochastic Oscillator
- KOD 36.51
- NKSH 0.00
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is KSI-301, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD.
About NKSH National Bankshares Inc.
National Bankshares Inc is a bank holding company. It focuses on lending to small and mid-sized businesses and individuals. The types of loans it offers include commercial and agricultural, commercial real estate, construction for commercial and residential properties, residential real estate, home equity, and various consumer loan products. It also operates an insurance and brokerage subsidiary, National Bankshares Financial Services, Inc. The company earns its revenues from interest and fees on loans, non-interest income, and investments.